Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03631953
Title Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas (ALTREM)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Assistance Publique Hopitaux De Marseille
Indications

meningioma

Therapies

Alpelisib + Trametinib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.